News | News By Subject | News by Disease News By Date | Search News

Cardiovascular Disorder (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
BIOCEO15: BioLineRx Ltd. CEO Touts New Celiac Drug, Fleshes Out Novartis AG (NVS) Partnership Terms     2/11/2015
Scientists Claim Scrapped Roche (RHHBY) Drug Could be First Personalized Heart Med     1/23/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine)     11/21/2014
Sanofi (SAN.PA) And Regeneron (REGN)'s Alirocumab Ph3 Trials Met Primary Efficacy Endpoint     11/20/2014
Merck & Co. (MRK)'s Vytorin Proves Effective; IMPROVE-IT Trial Achieves Primary Endpoint     11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
ZS Pharma (ZSPH) Presents Positive Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia, At The American Heart Association Scientific Meeting And Announces Simultaneous Publication Of Results In JAMA     11/17/2014
Alnylam Pharmaceuticals (ALNY) Reports Positive Initial Phase 2 Data With Revusiran     11/14/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option     11/13/2014
AstraZeneca PLC (AZN) To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta     11/13/2014
Cardiome Pharma Corp. (COM.TO) Touts Positive Data From Phase 3 BRINAVESS® Trial     11/7/2014
FDA Panel Backs Daiichi Sankyo, Inc. (4568.t)'s New A-Fib Drug Savaysa     10/31/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA)     9/17/2014
Wall Street Overreacting To Amarin (AMRN) Denial: Citigroup Analyst     9/12/2014

News from Around the Web
Coffee Prevents Clogged Arteries And Heart Attacks, Kangbuk Samsung Hospital Study     3/3/2015
Peanut Eaters May Live a Longer Life, Vanderbilt University Study     3/3/2015
Treadmill Performance Predicts Risk Of Death, Johns Hopkins University Study     3/2/2015
Elite Athletes's DNA May Hold The Secret To A Healthy Heart, Stanford University Study     2/27/2015
More Than 2 Hours Of TV A Day Ups High Blood Pressure Risk In Kids, Universidad de São Paulo Study     2/26/2015
Could Sauna Use Help You Live Longer? University Of Eastern Finland Study     2/25/2015
High Cholesterol In Mid-Life Risky For The Heart, Duke Clinical Research Institute Study     1/27/2015
Sitting Too Much? Even Exercise May Not Save You, University Health Network Study     1/21/2015
How Much Salt Should Older People Really Eat? Emory University Study     1/20/2015
Blueberries: Daily Cup May Reduce Blood Pressure, Florida State University Study     1/9/2015
An Avocado A Day Keeps Bad Cholesterol Away, Penn State University Study     1/9/2015
Hold Your Breath To Protect Your Heart, Thomas Jefferson University Study     1/7/2015
Eating Whole Grains Linked To A Longer Life, Harvard School of Public Health Study     1/6/2015
Only 4 In 10 Americans Eat Heart-Healthy Nuts Each Day, CDC Says     12/18/2014
Yoga May Guard Against Heart Disease, Erasmus MC Study Finds     12/17/2014

Press Releases
Acasti Pharma Receives Full Data For Phase II TRIFECTA Trial     3/2/2015
Merck & Co. (MRK) Release: New Data From IMPROVE-IT Study Of VYTORIN® (Ezetimibe/Simvastatin) And TRA 2ºp TIMI 50 Study Of ZONTIVITY® (Vorapaxar) To Be Presented At American College of Cardiology Scientific Sessions     2/25/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage     2/25/2015
Featured Lectures From Cardiology 2015: The 18th Annual Update On Pediatric And Congenital Cardiovascular Disease     2/16/2015
American Heart Association Release: Daily Beet Juice Lowers Blood Pressure for High Blood Pressure Sufferers     1/21/2015
AstraZeneca PLC (AZN)'s Brilinta Boosted by Major Clinical Trial Success     1/14/2015
Auspex Pharmaceuticals (ASPX) Announces Favorable Topline Results From Thorough QT Clinical Trial Of SD-809     1/12/2015
MaRS Innovation Announces Collaboration With Johnson & Johnson (JNJ) Innovation And Janssen To Advance Cardiac, Diabetes And Depression Technologies     1/12/2015
Biostar Pharmaceuticals, Inc. (BSPM) Announces Signing Of Joint Research And Development Agreement With Northwest University For Further Development Of Danshensu Yibingzhi (IDHP), A Class One Drug For Treatment Of Cardiovascular Diseases     1/8/2015
Biocryst Pharmaceuticals (BCRX) Receives Orphan Drug Designation For BCX4161 For The Treatment Of Hereditary Angioedema     12/24/2014
New Published Data Show Pluristem Therapeutics (PSTI)'s PLX Cells Protect Neurons     12/22/2014
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF     12/19/2014
Additional Clinical Data From The Phase 2 Study With Ablynx (ABLYF)'s Anti-vWF Nanobody, Caplacizumab, Presented At The American Society of Hematology Annual Meeting     12/8/2014
Milestone Pharmaceuticals Announces Positive Phase 1 Data For MSP-2017; Supports Advancement Into Phase 2 In PSVT Patients     11/24/2014
Kaiser Permanente Release: Digoxin Associated With Higher Risk of Death and Hospitalization in Adults With Atrial Fibrillation and No Heart Failure     11/21/2014

//-->